Agios Pharmaceuticals, Inc. has appointed Bruce Car, Ph.D., as chief scientific officer, effective January 6, 2020. Dr. Car succeeds Scott Biller, Ph.D., who will retire at the end of the year and remain a strategic advisor through 2020. Dr. Car spent 25 years at Bristol-Myers Squibb (BMS) and its legacy companies, working across all therapeutic areas and drug modalities, and serving most recently as the interim head, BMS drug discovery. “Great science is the backbone of Agios and what allows u...